BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28573905)

  • 1. Regulatory T-cells drive immune dysfunction in CLL.
    Lad D; Hoeppli R; Huang Q; Garcia R; Xu L; Toze C; Broady R; Levings M
    Leuk Lymphoma; 2018 Feb; 59(2):486-489. PubMed ID: 28573905
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias.
    Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
    Leuk Lymphoma; 2013 May; 54(5):1012-9. PubMed ID: 23009220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.
    Yousefi M; Movassaghpour AA; Shamsasenjan K; Ghalamfarsa G; Sadreddini S; Jadidi-Niaragh F; Hojjat-Farsangi M
    Future Oncol; 2015; 11(10):1567-82. PubMed ID: 25963433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.
    Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
    Leuk Lymphoma; 2015; 56(8):2424-8. PubMed ID: 25393804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells in chronic lymphocytic leukemia: some progress and a bit of "tolerance" in understanding disease progression.
    Perry C; Polliack A
    Leuk Lymphoma; 2013 May; 54(5):903-4. PubMed ID: 23140226
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3.
    Dasgupta A; Mahapatra M; Saxena R
    Leuk Lymphoma; 2013 Apr; 54(4):778-89. PubMed ID: 22989355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
    Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
    Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
    Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia.
    Dasgupta A; Mahapatra M; Saxena R
    Leuk Lymphoma; 2015 Jun; 56(6):1831-8. PubMed ID: 25263321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia.
    Mpakou VE; Ioannidou HD; Konsta E; Vikentiou M; Spathis A; Kontsioti F; Kontos CK; Velentzas AD; Papageorgiou S; Vasilatou D; Gkontopoulos K; Glezou I; Stavroulaki G; Mpazani E; Kokkori S; Kyriakou E; Karakitsos P; Dimitriadis G; Pappa V
    Leuk Res; 2017 Sep; 60():74-81. PubMed ID: 28759799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.
    Perry C; Herishanu Y; Hazan-Halevy I; Kay S; Bdolach N; Naparstek E; Polliack A; Grisaru D
    Leuk Lymphoma; 2012 Sep; 53(9):1807-10. PubMed ID: 22242820
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia.
    Wallace ME; Alcantara MB; Minoda Y; Kannourakis G; Berzins SP
    Int Immunopharmacol; 2015 Oct; 28(2):897-900. PubMed ID: 25862133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
    De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
    Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia.
    Rissiek A; Schulze C; Bacher U; Schieferdecker A; Thiele B; Jacholkowski A; Flammiger A; Horn C; Haag F; Tiegs G; Zirlik K; Trepel M; Tolosa E; Binder M
    Int J Cancer; 2014 Nov; 135(10):2370-9. PubMed ID: 24723150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
    Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDSCs: the final frontier of the microenvironment in CLL?
    Zirlik K
    Blood; 2014 Jul; 124(5):666-8. PubMed ID: 25082859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis.
    D'Arena G; Rossi G; Minervini MM; Savino L; D'Auria F; Laurenti L; Del Principe MI; Deaglio S; Biagi A; De Martino L; De Feo V; Statuto T; Musto P; Del Poeta G
    Int J Immunopathol Pharmacol; 2011; 24(4):915-23. PubMed ID: 22230398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide.
    Giannopoulos K; Schmitt M; Własiuk P; Chen J; Bojarska-Junak A; Kowal M; Roliñski J; Dmoszyñska A
    Leukemia; 2008 Jan; 22(1):222-4. PubMed ID: 17657216
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Mactier S; Armacki N; Giles Best O; Belov L; Kaufman KL; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2016 May; 57(5):1033-43. PubMed ID: 26422656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.